Filing metadata

Accession number
0001600620-24-000036
Form type
Form 4
Filer
Aurinia Pharmaceuticals Inc.
CIK
CIK 1600620
Filed
Mar 07, 2024
Reporting period
Mar 06, 2024
Description
Insider transaction

Explore SEC Filings Hub